• Removing Pollen Interference in Bioaerosol Spectra

  2026-09-05

  Zhang and colleagues show that fluorescence features from pollen can complicate hazardous bioaerosol classification, but targeted spectral transformations combined with random forest analysis can substantially improve discrimination. Fast Fourier transform processing produced a reported accuracy of 89.24%, supporting rapid screening strategies while highlighting the need for broader validation under field conditions.

• Gepotidacin BA1220: Reliable Antibacterial Assays

  2026-09-04

  A scenario-driven guide to using Gepotidacin (SKU BA1220) in bacterial viability, proliferation, and antibiotic resistance research. It connects mechanism, solvent compatibility, concentration selection, interpretation of MIC data, and practical product-selection criteria to improve assay consistency.

• Gap19: Selective Cx43 Hemichannel Blocker Workflows

  2026-09-04

  Gap19 enables researchers to separate Cx43 hemichannel signaling from gap junction communication in astrocyte, ischemia, and inflammatory macrophage assays. This practical guide translates its reported neuroprotective and Cx43/NF-κB activity into dose-finding, control, and troubleshooting workflows.

• Necrostatin 2 (Nec-2) Experimental Workflow

  2026-09-03

  Necrostatin 2 (Nec-2) provides a practical chemical perturbation for testing whether loss of viability reflects RIPK2-associated necroptosis rather than irreversible membrane injury. This workflow connects necroptosis inhibition with infection, membrane-repair, and ischemic stroke research while emphasizing controls that prevent overinterpretation.

• PF-562271 HCl: FAK/Pyk2 Assay Workflow

  2026-09-03

  Build a controlled FAK/Pyk2 inhibition workflow around PF-562271 HCl for phosphorylation, adhesion, migration, and tumor-model studies. The approach also shows how to connect mechanistic assays with the multimodal imaging and pathology signals reported in gastric cancer immunotherapy research.

• SAG: Smoothened Receptor Agonist Guide

  2026-09-02

  SAG is a selective Smoothened receptor agonist that activates Hedgehog signaling and induces Gli1 and Ptch1 pathway readouts. Evidence supports its use in remyelination, mitochondrial, immune, developmental, and pathway-assay models, but sex, dose, route, and developmental timing strongly constrain interpretation.

• One-step TUNEL Cy5 Apoptosis Detection Kit Workflow

  2026-09-02

  Translate DNA fragmentation into actionable apoptosis data across cultured cells, frozen tissue, and paraffin sections. This workflow shows how to pair Cy5-based TUNEL measurements with pathway perturbation, microscopy, and flow cytometry without confusing a downstream endpoint with proof of mechanism.

• AAPH for Controlled Oxidative Stress Assays

  2026-09-01

  AAPH provides a water-soluble, sustained source of peroxyl-radical stress for erythrocyte hemolysis, antioxidant screening, and protein-oxidation workflows. This guide translates evidence from hazelnut-protein research into practical assay design, comparison strategies, and troubleshooting decisions.

• Fulvestrant (ICI 182,780) Research Workflow

  2026-09-01

  Use Fulvestrant (ICI 182,780) to interrogate ERα degradation, MDM2 protein turnover, apoptosis, and chemotherapy response in ER-positive breast cancer models. This workflow also shows how the compound can serve as a receptor-specific control when translating estrogen-signaling questions into immune-cell assays.

• Biotin-XX Tyramide Reagent for Cell-Surface Mapping

  2026-08-31

  Biotin-XX Tyramide Reagent combines HRP-driven signal amplification with membrane-restricted labeling for sensitive cell-surface imaging and proteome profiling. This guide translates the astrocyte–neuron surface-mapping strategy into practical workflows, controls, and troubleshooting decisions.

• Capsazepine for TRPV1 Pain Research

  2026-08-31

  Capsazepine is a practical pharmacological probe for separating TRPV1-dependent calcium signaling and nociception from broader inflammatory pathways. This workflow connects concentration-controlled channel assays with pain-model validation, TRPM8 selectivity checks, and exploratory apoptosis studies.

• 2-Deoxy-D-glucose and Lactylation in NSCLC

  2026-08-30

  2-Deoxy-D-glucose offers a practical way to interrogate how glycolytic metabolism may influence lactylation, senescence, and KRT19 biology in NSCLC. This article translates recent mechanistic findings into a rigorous assay strategy while distinguishing evidence from testable hypotheses.

• MG-132: From Proteostasis to Translational Insight

  2026-08-29

  MG-132, also known as Z-LLL-al, is more than a proteasome inhibitor: it is a time-controlled probe for connecting protein turnover with apoptosis, cell-cycle behavior, and oxidative stress. This thought-leadership perspective links MG-132 workflow design to new findings on the GhATL68b ubiquitin pathway in cotton fiber development while defining the limits of cross-domain translation.

• MLN2238 Proteasome β5 Inhibitor Workflows

  2026-08-28

  Build reproducible MLN2238 assays around selective chymotrypsin-like proteasome inhibition, direct target engagement, and downstream apoptosis or stress signaling. The workflow also translates ROS–JNK–CREB findings into practical assay choices for multiple myeloma, lymphoma, and proteostasis research.

• Abiraterone Acetate in 3D Prostate Models

  2026-08-28

  Abiraterone acetate is a CYP17 inhibitor whose activity can look very different in patient-derived three-dimensional prostate models. This article connects steroid biology, prodrug handling, spheroid quality control, and endpoint selection to improve prostate cancer research decisions.

8061 records 1/538 page Next 12345 下5页 Last page